Summary
Agilent Technologies, Inc. reported a strong fiscal year ended October 31, 2011, with net revenue increasing by 22% to $6.615 billion. This growth was significantly bolstered by the acquisition of Varian, Inc. in May 2010, which contributed approximately 5 percentage points to the revenue increase after accounting for divested businesses. The company's net income saw a substantial rise to $1.012 billion from $684 million in the prior year, reflecting improved operating results and effective management of expenses. The company's performance was driven by broad-based improvements across its three key business segments: Life Sciences, Chemical Analysis, and Electronic Measurement. The Life Sciences segment experienced a 21% revenue increase, supported by strong performance in LC-MS and genomics products, while the Chemical Analysis segment grew 27%, driven by demand in petrochemical and food safety markets. The Electronic Measurement segment saw a 19% revenue increase, with strong performance in both general-purpose and communications test markets. Agilent ended the fiscal year with a healthy cash position of $3.5 billion, indicating sound financial management. The company continued its investment in research and development, demonstrating a commitment to innovation and future growth. Looking ahead, Agilent remains focused on integrating its acquisitions, driving cost synergies, and expanding its market presence, particularly in emerging markets.
Financial Highlights
59 data points| Revenue | $6.62B |
| Cost of Revenue | $3.09B |
| Gross Profit | $3.53B |
| R&D Expenses | $649.00M |
| SG&A Expenses | $1.81B |
| Operating Expenses | $5.54B |
| Operating Income | $1.07B |
| Interest Expense | $86.00M |
| Net Income | $1.01B |
| EPS (Basic) | $2.92 |
| EPS (Diluted) | $2.85 |
| Shares Outstanding (Basic) | 347.00M |
| Shares Outstanding (Diluted) | 355.00M |
Key Highlights
- 1Net revenue increased by 22% to $6.615 billion for the fiscal year ended October 31, 2011.
- 2Net income rose significantly to $1.012 billion, up from $684 million in the previous year.
- 3The acquisition of Varian, Inc. in May 2010 was a key driver of growth, contributing approximately 5% to the revenue increase.
- 4All three business segments – Life Sciences, Chemical Analysis, and Electronic Measurement – showed robust revenue growth.
- 5The company ended the fiscal year with strong liquidity, holding $3.527 billion in cash and cash equivalents.
- 6Operating income from operations for the electronic measurement business saw a significant increase of 74% year-over-year.
- 7Agilent maintained its commitment to R&D, with expenditures of $649 million for the fiscal year.